AAAAAA

   
Results: 1-14 |
Results: 14
DISCOVERY OF YDROXYPROPYL]-(4S)-(4-HYDROXYPHENYL)-2-AZETIDINONE (SCH-58235) - A DESIGNED, POTENT, ORALLY-ACTIVE INHIBITOR OF CHOLESTEROL ABSORPTION
Authors: ROSENBLUM SB HUYNH T AFONSO A DAVIS HR YUMIBE N CLADER JW BURNETT DA
Citation: Sb. Rosenblum et al., DISCOVERY OF YDROXYPROPYL]-(4S)-(4-HYDROXYPHENYL)-2-AZETIDINONE (SCH-58235) - A DESIGNED, POTENT, ORALLY-ACTIVE INHIBITOR OF CHOLESTEROL ABSORPTION, Journal of medicinal chemistry, 41(6), 1998, pp. 973-980
DO SHORTER-ACTING NEUROMUSCULAR BLOCKING-DRUGS OR OPIOIDS ASSOCIATE WITH REDUCED INTENSIVE-CARE UNIT OR HOSPITAL LENGTHS OF STAY AFTER CORONARY-ARTERY BYPASS-GRAFTING
Authors: BUTTERWORTH J JAMES R STAT M PRIELIPP RC CERESE J LIVINGSTON J BURNETT DA
Citation: J. Butterworth et al., DO SHORTER-ACTING NEUROMUSCULAR BLOCKING-DRUGS OR OPIOIDS ASSOCIATE WITH REDUCED INTENSIVE-CARE UNIT OR HOSPITAL LENGTHS OF STAY AFTER CORONARY-ARTERY BYPASS-GRAFTING, Anesthesiology, 88(6), 1998, pp. 1437-1446
CLINICAL-TRIALS IN DEPARTMENTS OF INTERNAL-MEDICINE
Authors: VLASSES PH BURNETT DA
Citation: Ph. Vlasses et Da. Burnett, CLINICAL-TRIALS IN DEPARTMENTS OF INTERNAL-MEDICINE, The American journal of medicine, 105(2), 1998, pp. 170-171
EVOLVING MARKET WILL CHANGE CLINICAL RESEARCH
Authors: BURNETT DA
Citation: Da. Burnett, EVOLVING MARKET WILL CHANGE CLINICAL RESEARCH, Health affairs, 15(3), 1996, pp. 90-92
2-AZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS - STRUCTURE-ACTIVITY-RELATIONSHIPS ON THE HETEROCYCLIC NUCLEUS
Authors: CLADER JW BURNETT DA CAPLEN MA DOMALSKI MS DUGAR S VACCARO W SHER R BROWNE ME ZHAO HR BURRIER RE SALISBURY B DAVIS HR
Citation: Jw. Clader et al., 2-AZETIDINONE CHOLESTEROL ABSORPTION INHIBITORS - STRUCTURE-ACTIVITY-RELATIONSHIPS ON THE HETEROCYCLIC NUCLEUS, Journal of medicinal chemistry, 39(19), 1996, pp. 3684-3693
DEVICE EVALUATION AND THE FOOD-AND-DRUG-ADMINISTRATION PROCESS - JULY, 1994
Authors: KIMMEY MB BURNETT DA ALKAWAS FH CARRLOCKE DL GANNAN RM SAEED ZA SCOBEY MW STEIN TN STEINBERG SM DIMARINO AJ
Citation: Mb. Kimmey et al., DEVICE EVALUATION AND THE FOOD-AND-DRUG-ADMINISTRATION PROCESS - JULY, 1994, Gastrointestinal endoscopy, 43(6), 1996, pp. 641-644
SURVEILLANCE OF COLONY-STIMULATING FACTOR USE IN US ACADEMIC HEALTH CENTERS
Authors: YIM JM MATUSZEWSKI KA VERMEULEN LC RATKO TA BURNETT DA VLASSES PH
Citation: Jm. Yim et al., SURVEILLANCE OF COLONY-STIMULATING FACTOR USE IN US ACADEMIC HEALTH CENTERS, The Annals of pharmacotherapy, 29(5), 1995, pp. 475-481
RECOMMENDATIONS FOR OFF-LABEL USE OF INTRAVENOUSLY ADMINISTERED IMMUNOGLOBULIN PREPARATIONS
Authors: RATKO TA BURNETT DA FOULKE GE MATUSZEWSKI KA SACHER RA EHMANN WC GIVNER LB KAHALEH B MATUSZEWSKI KA SAMAHA FJ SIEGEL J WINGARD JR WORDELL CJ YOCUM DE
Citation: Ta. Ratko et al., RECOMMENDATIONS FOR OFF-LABEL USE OF INTRAVENOUSLY ADMINISTERED IMMUNOGLOBULIN PREPARATIONS, JAMA, the journal of the American Medical Association, 273(23), 1995, pp. 1865-1870
TRANS DIASTEREOSELECTIVE SYNTHESIS OF 3-ALKYL SUBSTITUTED BETA-LACTAMS VIA THE ACID CHLORIDE-IMINE REACTION OF NONACTIVATED ACID-CHLORIDES
Authors: BROWNE M BURNETT DA CAPLEN MA CHEN LY CLADER JW DOMALSKI M DUGAR S PUSHPAVANAM P SHER R VACCARO W VIZIANO M ZHAO HR
Citation: M. Browne et al., TRANS DIASTEREOSELECTIVE SYNTHESIS OF 3-ALKYL SUBSTITUTED BETA-LACTAMS VIA THE ACID CHLORIDE-IMINE REACTION OF NONACTIVATED ACID-CHLORIDES, Tetrahedron letters, 36(15), 1995, pp. 2555-2558
HYPOCHOLESTEROLEMIC ACTIVITY OF A NOVEL INHIBITOR OF CHOLESTEROL ABSORPTION, SCH-48461
Authors: SALISBURY BG DAVIS HR BURRIER RE BURNETT DA BOYKOW G CAPLEN MA CLEMMONS AL COMPTON DS HOOS LM MCGREGOR DG SCHNITZERPOLOKOFF R SMITH AA WEIG BC ZILLI DL CLADER JW SYBERTZ EJ
Citation: Bg. Salisbury et al., HYPOCHOLESTEROLEMIC ACTIVITY OF A NOVEL INHIBITOR OF CHOLESTEROL ABSORPTION, SCH-48461, Atherosclerosis, 115(1), 1995, pp. 45-63
ALBUMIN AND NONPROTEIN COLLOID SOLUTION USE IN US ACADEMIC HEALTH CENTERS
Authors: YIM JM VERMEULEN LC ERSTAD BL MATUSZEWSKI KA BURNETT DA VLASSES PH
Citation: Jm. Yim et al., ALBUMIN AND NONPROTEIN COLLOID SOLUTION USE IN US ACADEMIC HEALTH CENTERS, Archives of internal medicine, 155(22), 1995, pp. 2450-2455
ASYMMETRIC-SYNTHESIS AND ABSOLUTE STEREOCHEMISTRY OF CHOLESTEROL ABSORPTION INHIBITOR, SCH-48461
Authors: BURNETT DA
Citation: Da. Burnett, ASYMMETRIC-SYNTHESIS AND ABSOLUTE STEREOCHEMISTRY OF CHOLESTEROL ABSORPTION INHIBITOR, SCH-48461, Tetrahedron letters, 35(40), 1994, pp. 7339-7342
2-AZETIDINONES AS INHIBITORS OF CHOLESTEROL ABSORPTION
Authors: BURNETT DA CAPLEN MA DAVIS HR BURRIER RE CLADER JW
Citation: Da. Burnett et al., 2-AZETIDINONES AS INHIBITORS OF CHOLESTEROL ABSORPTION, Journal of medicinal chemistry, 37(12), 1994, pp. 1733-1736
EVALUATION OF ONDANSETRON PRESCRIBING IN US ACADEMIC MEDICAL-CENTERS
Authors: VERMEULEN LC MATUSZEWSKI KA RATKO TA BUTLER CD BURNETT DA VLASSES PH
Citation: Lc. Vermeulen et al., EVALUATION OF ONDANSETRON PRESCRIBING IN US ACADEMIC MEDICAL-CENTERS, Archives of internal medicine, 154(15), 1994, pp. 1733-1740
Risultati: 1-14 |